| 股票 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▴ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 爱威科技 688067 | 医疗器械 | 49.1 | — | — | 3.04 | 0.6% | 31% | 59% | 21% | 1.0 | 1.9% | +4% | +48% | -4% | -14% | -38% | 36% | 16 |
| 科美诊断 688468 | 医疗器械 | 72.2 | — | — | 1.78 | — | 36% | 75% | 24% | 2.6 | 2.9% | -11% | +9% | -14% | -28% | -37% | 27% | 25 |
| 丹娜生物 920009 | 医疗器械 | 30.6 | 23.4 | 1.30 | 4.12 | 1.0% | 25% | 84% | 9% | 0.0 | 2.1% | -6% | — | -31% | — | — | — | 29 |
| 赛科希德 688338 | 医疗器械 | 38.6 | 35.1 | 2.34 | 1.90 | 0.8% | 31% | 62% | 17% | — | 1.5% | +5% | +9% | +19% | +10% | -33% | 46% | 32 |
| 美康生物 300439 | 医疗器械 | 52.1 | — | — | 1.18 | 0.4% | 20% | 40% | 30% | 0.4 | 2.3% | -15% | -4% | -6% | -19% | -31% | 27% | 36 |
| 基蛋生物 603387 | 医疗器械 | 15.9 | — | — | 1.60 | 2.6% | 41% | 67% | 19% | 0.9 | 6.6% | -17% | +4% | +13% | +8% | -28% | 38% | 47 |
| 博拓生物 688767 | 医疗器械 | 275.9 | 54.6 | 2.60 | 2.62 | 1.9% | 186% | 53% | 24% | 1.8 | -1.3% | -38% | +70% | +1% | -7% | -37% | 61% | 56 |
| 亚辉龙 688575 | 医疗器械 | 86.0 | 34.1 | 1.18 | 2.10 | 0.2% | 43% | 57% | 39% | 1.8 | 2.8% | -23% | -9% | -29% | -38% | -48% | 33% | 58 |
| 浩欧博 688656 | 医疗器械 | 239.5 | — | — | 7.98 | 0.2% | 54% | 63% | 71% | 0.3 | 0.8% | +8% | +62% | -32% | -16% | -63% | 55% | 66 |
| 九安医疗 002432 | 医疗器械 | 7.1 | — | — | 1.36 | 2.2% | 11% | 64% | 1% | — | -1.9% | -63% | -1% | +76% | +68% | -39% | 64% | 315 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。